DoH guidance ‘contradicts’ NICE on Alzheimer’s care

DoH guidance on care for older people contradicts NICE recommendations over treatment for Alzheimer’s disease, say experts.

DoH contradicts NICE on Alzheimer's care
DoH contradicts NICE on Alzheimer's care

The latest report from DoH older peoples' czar Professor Ian Philp endorses early intervention for dementia because it 'has been shown to help sufferers and their families enjoy a higher quality of life and reduce the need for admission to care homes'.

In contrast, the NICE final technology appraisal said cholinesterase inhibitors should not be initiated in patients with mild Alzheimer's disease (GP, 13 October 2006). This is despite the drugs being regarded as the most effective available treatment for Alzheimer's.

However, Professor Philp argued that his report and advice from NICE do 'marry up' because NICE endorsed cholinesterase inhibitor use for patients with a mini mental state examination score of 10-20, which it says is when it becomes effective.

'There are many people who oppose this narrow interval for use,' said Professor Philp, but he refused to comment on whether or not he agreed with NICE.

rachel.liddle@haymarket.com and nick.bostock@haymarket.com  

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus
Follow Us: